Hyper-Capitalist Zone | Total HC Population (2060) | Estimated Consistent NeoGuard™ Users (SNP-Dormant/Elite) | Estimated Partial/Conditional NeoGuard™ Users (Key Bioinsecure Workforce) | Estimated Planetary NeoGuard™ Sales Units (Annual Estimate - 2060) | Dominant Supplier(s) |
---|---|---|---|---|---|
DRCAA (Kinshasa-Brazzaville & Territories) | ~30 Million | ~4.5 Million (15%) | ~15 Million (50%) | ~240 Million Units | CSC Affiliates, Roche-Takeda |
Indian Megacity Complex & Associates (India, Bangladesh, Sri Lanka) | ~73.4 Million | ~14.7 Million (20%) | ~36.7 Million (50%) | ~585 Million Units | Sun Pharmaceuticals, Local Conglomerates |
UAE Zone (Dubai, Abu Dhabi, Jeddah, Tel Aviv, Sinai) | ~10 Million | ~2 Million (20%) | ~4 Million (40%) | ~70 Million Units | Roche-Takeda, Sun Pharmaceuticals, Regional Distributors |
Addis Ababa (Ethiopia) | ~1.5 Million | ~0.2 Million (13%) | ~0.6 Million (40%) | ~10 Million Units | CSC Affiliates, Regional Traders |
Medellin (Colombia) | ~1 Million | ~0.2 Million (20%) | ~0.4 Million (40%) | ~7 Million Units | Roche-Takeda, Sun Pharmaceuticals, Local Cartels |
Northern Italy | ~3 Million | ~0.4 Million (13%) | ~1.2 Million (40%) | ~20 Million Units | Roche-Takeda, Unconventional OPEs |
Other Dispersed Hyper-Capitalist Populations | ~1 Million | ~0.1 Million (10%) | ~0.3 Million (30%) | ~5 Million Units | Various (Sun, Roche-Takeda, Unconventional OPEs) |
TOTALS | ~120 Million | ~22.1 Million (18.4%) | ~58.2 Million (48.5%) | ~937 Million Units | Sun Pharma, Roche-Takeda, CSC Affiliates, Others |
In the fragmented reality of 2060, where the synthetic nano-parasites (SNP/NanoSinp) remain an endemic threat factor outside of EPSCOM's most controlled environments, the hyper-capitalist enclaves rely heavily on a specific pharmacological intervention: NeoGuard™.
This compound, notably developed and distributed by corporations like Sun Pharmaceuticals or Roche-Takeda, represents a cornerstone technology enabling the continued, albeit precarious, functioning of their stratified societies.
It must be emphasized that NeoGuard™ is a treatment, not a cure; it offers no pathway to the eradication of the alien nano-parasites themselves.
NeoGuard™ operates by inducing a state of dormancy within the SNPs hosted inside the human body, thereby mitigating the most severe symptoms of cognitive decline and physical deterioration that define the unmanaged bioinsecure condition.
This pharmacological suppression allows a semblance of pre-collapse operational capacity, particularly crucial for the hyper-capitalist elites, who maintain control over its production and distribution networks.
Access to NeoGuard™ is thus primarily an instrument of power and social control, a perversion of the biosecurity capital concept. The ruling echelons ensure consistent dosage for themselves and key personnel, while providing limited, often conditional, access to the broader bioinsecure workforce, cultivating dependence and reinforcing the rigid hierarchies upon which their economic model depends.
The production itself involves the cultivation of modified synthetic nano-parasites (modSNPs) – the core biological component originally reverse-engineered and cultured by resourceful, though inevitably bioinsecure, biohackers and pioneering scientists operating within the collapsing landscape of former Poland during the earlier phases of the dual crisis.
This cultivation process is deemed biologically hazardous and ethically abhorrent by EPSCOM standards.
Ultimately, NeoGuard™ represents a technological adaptation to persistent bioinsecurity, a means to manage rather than resolve the SNP crisis, standing in clear opposition to the principles of biosecurity and systemic flourishing pursued within the Transhuman Eudaimonist biosecurity safezones.
Hyper-capitalist Key Technology: NeoGuard™


Hyper-Capitalist Zone | Total HC Population (2060) | Estimated Consistent NeoGuard™ Users (SNP-Dormant/Elite) | Estimated Partial/Conditional NeoGuard™ Users (Key Bioinsecure Workforce) | Estimated Planetary NeoGuard™ Sales Units (Annual Estimate - 2060) | Dominant Supplier(s) |
---|---|---|---|---|---|
DRCAA (Kinshasa-Brazzaville & Territories) | ~30 Million | ~4.5 Million (15%) | ~15 Million (50%) | ~240 Million Units | CSC Affiliates, Roche-Takeda |
Indian Megacity Complex & Associates (India, Bangladesh, Sri Lanka) | ~73.4 Million | ~14.7 Million (20%) | ~36.7 Million (50%) | ~585 Million Units | Sun Pharmaceuticals, Local Conglomerates |
UAE Zone (Dubai, Abu Dhabi, Jeddah, Tel Aviv, Sinai) | ~10 Million | ~2 Million (20%) | ~4 Million (40%) | ~70 Million Units | Roche-Takeda, Sun Pharmaceuticals, Regional Distributors |
Addis Ababa (Ethiopia) | ~1.5 Million | ~0.2 Million (13%) | ~0.6 Million (40%) | ~10 Million Units | CSC Affiliates, Regional Traders |
Medellin (Colombia) | ~1 Million | ~0.2 Million (20%) | ~0.4 Million (40%) | ~7 Million Units | Roche-Takeda, Sun Pharmaceuticals, Local Cartels |
Northern Italy | ~3 Million | ~0.4 Million (13%) | ~1.2 Million (40%) | ~20 Million Units | Roche-Takeda, Unconventional OPEs |
Other Dispersed Hyper-Capitalist Populations | ~1 Million | ~0.1 Million (10%) | ~0.3 Million (30%) | ~5 Million Units | Various (Sun, Roche-Takeda, Unconventional OPEs) |
TOTALS | ~120 Million | ~22.1 Million (18.4%) | ~58.2 Million (48.5%) | ~937 Million Units | Sun Pharma, Roche-Takeda, CSC Affiliates, Others |
In the fragmented reality of 2060, where the synthetic nano-parasites (SNP/NanoSinp) remain an endemic threat factor outside of EPSCOM's most controlled environments, the hyper-capitalist enclaves rely heavily on a specific pharmacological intervention: NeoGuard™.
This compound, notably developed and distributed by corporations like Sun Pharmaceuticals or Roche-Takeda, represents a cornerstone technology enabling the continued, albeit precarious, functioning of their stratified societies.
It must be emphasized that NeoGuard™ is a treatment, not a cure; it offers no pathway to the eradication of the alien nano-parasites themselves.
NeoGuard™ operates by inducing a state of dormancy within the SNPs hosted inside the human body, thereby mitigating the most severe symptoms of cognitive decline and physical deterioration that define the unmanaged bioinsecure condition.
This pharmacological suppression allows a semblance of pre-collapse operational capacity, particularly crucial for the hyper-capitalist elites, who maintain control over its production and distribution networks.
Access to NeoGuard™ is thus primarily an instrument of power and social control, a perversion of the biosecurity capital concept. The ruling echelons ensure consistent dosage for themselves and key personnel, while providing limited, often conditional, access to the broader bioinsecure workforce, cultivating dependence and reinforcing the rigid hierarchies upon which their economic model depends.
The production itself involves the cultivation of modified synthetic nano-parasites (modSNPs) – the core biological component originally reverse-engineered and cultured by resourceful, though inevitably bioinsecure, biohackers and pioneering scientists operating within the collapsing landscape of former Poland during the earlier phases of the dual crisis.
This cultivation process is deemed biologically hazardous and ethically abhorrent by EPSCOM standards.
Ultimately, NeoGuard™ represents a technological adaptation to persistent bioinsecurity, a means to manage rather than resolve the SNP crisis, standing in clear opposition to the principles of biosecurity and systemic flourishing pursued within the Transhuman Eudaimonist biosecurity safezones.
Hyper-capitalist Key Technology: NeoGuard™


Hyper-Capitalist Zone | Total HC Population (2060) | Estimated Consistent NeoGuard™ Users (SNP-Dormant/Elite) | Estimated Partial/Conditional NeoGuard™ Users (Key Bioinsecure Workforce) | Estimated Planetary NeoGuard™ Sales Units (Annual Estimate - 2060) | Dominant Supplier(s) |
---|---|---|---|---|---|
DRCAA (Kinshasa-Brazzaville & Territories) | ~30 Million | ~4.5 Million (15%) | ~15 Million (50%) | ~240 Million Units | CSC Affiliates, Roche-Takeda |
Indian Megacity Complex & Associates (India, Bangladesh, Sri Lanka) | ~73.4 Million | ~14.7 Million (20%) | ~36.7 Million (50%) | ~585 Million Units | Sun Pharmaceuticals, Local Conglomerates |
UAE Zone (Dubai, Abu Dhabi, Jeddah, Tel Aviv, Sinai) | ~10 Million | ~2 Million (20%) | ~4 Million (40%) | ~70 Million Units | Roche-Takeda, Sun Pharmaceuticals, Regional Distributors |
Addis Ababa (Ethiopia) | ~1.5 Million | ~0.2 Million (13%) | ~0.6 Million (40%) | ~10 Million Units | CSC Affiliates, Regional Traders |
Medellin (Colombia) | ~1 Million | ~0.2 Million (20%) | ~0.4 Million (40%) | ~7 Million Units | Roche-Takeda, Sun Pharmaceuticals, Local Cartels |
Northern Italy | ~3 Million | ~0.4 Million (13%) | ~1.2 Million (40%) | ~20 Million Units | Roche-Takeda, Unconventional OPEs |
Other Dispersed Hyper-Capitalist Populations | ~1 Million | ~0.1 Million (10%) | ~0.3 Million (30%) | ~5 Million Units | Various (Sun, Roche-Takeda, Unconventional OPEs) |
TOTALS | ~120 Million | ~22.1 Million (18.4%) | ~58.2 Million (48.5%) | ~937 Million Units | Sun Pharma, Roche-Takeda, CSC Affiliates, Others |
In the fragmented reality of 2060, where the synthetic nano-parasites (SNP/NanoSinp) remain an endemic threat factor outside of EPSCOM's most controlled environments, the hyper-capitalist enclaves rely heavily on a specific pharmacological intervention: NeoGuard™.
This compound, notably developed and distributed by corporations like Sun Pharmaceuticals or Roche-Takeda, represents a cornerstone technology enabling the continued, albeit precarious, functioning of their stratified societies.
It must be emphasized that NeoGuard™ is a treatment, not a cure; it offers no pathway to the eradication of the alien nano-parasites themselves.
NeoGuard™ operates by inducing a state of dormancy within the SNPs hosted inside the human body, thereby mitigating the most severe symptoms of cognitive decline and physical deterioration that define the unmanaged bioinsecure condition.
This pharmacological suppression allows a semblance of pre-collapse operational capacity, particularly crucial for the hyper-capitalist elites, who maintain control over its production and distribution networks.
Access to NeoGuard™ is thus primarily an instrument of power and social control, a perversion of the biosecurity capital concept. The ruling echelons ensure consistent dosage for themselves and key personnel, while providing limited, often conditional, access to the broader bioinsecure workforce, cultivating dependence and reinforcing the rigid hierarchies upon which their economic model depends.
The production itself involves the cultivation of modified synthetic nano-parasites (modSNPs) – the core biological component originally reverse-engineered and cultured by resourceful, though inevitably bioinsecure, biohackers and pioneering scientists operating within the collapsing landscape of former Poland during the earlier phases of the dual crisis.
This cultivation process is deemed biologically hazardous and ethically abhorrent by EPSCOM standards.
Ultimately, NeoGuard™ represents a technological adaptation to persistent bioinsecurity, a means to manage rather than resolve the SNP crisis, standing in clear opposition to the principles of biosecurity and systemic flourishing pursued within the Transhuman Eudaimonist biosecurity safezones.
Hyper-capitalist Key Technology: NeoGuard™

